| |
N(%)
|
OR
|
95% CI
|
χ2
|
P
|
|---|
|
Females
|
24 (22.2)
|
2.4
|
0.5-10.6
|
1.3
|
0.244
|
|
North-Center
|
20 (23.8)
|
2.0
|
0.7-6.0
|
1.7
|
0.194
|
|
Age 18-24
|
2 (10.0)
|
1.01
|
0.95-1.1
|
0.1
|
0.6
|
|
Age 25-64
|
19 (17.4)
|
0.5
|
0.9-1.3
|
1.1
|
0.291
|
|
Age > 64
|
6 (33.3)
|
2.3
|
0.6-8.8
|
1.5
|
0.214
|
|
*MDQ > 7
|
7.5 (41.7)
|
3.6
|
1.1-40.5
|
4.8
|
0.028
|
|
*Comorbidity PD
|
9.6 (53.3)
|
17.2
|
6-49.2
|
27.2
|
0.0001
|
|
*Comorbidity DOC
|
2.8 (40.0)
|
2.9
|
0.5-1.3
|
0.8
|
0.369
|
|
*Comorbidity GAD
|
6.9 (43.1)
|
4.2
|
1.2-13.8
|
5.6
|
0.018
|
- *Standardized by age, sex and residence (N/S); °Vs overall sample receiving ADs (with exclusion of DE point prevalence)°°The Odds Ratio is calculated vs all other age frequencies
